More about

Catheter

News
November 15, 2023
1 min read
Save

FDA approves DefenCath for adults with kidney failure on chronic hemodialysis

FDA approves DefenCath for adults with kidney failure on chronic hemodialysis

The FDA has approved DefenCath, a catheter lock solution of taurolidine and heparin by CorMedix Inc., for adults with kidney failure on chronic hemodialysis, according to a press release.

News
November 14, 2023
1 min read
Save

Racial, ethnic differences seen in arteriovenous access after hemodialysis initiation

Racial, ethnic differences seen in arteriovenous access after hemodialysis initiation

PHILADELPHIA — Racial and ethnic differences exist in arteriovenous access use in patients 1 year after hemodialysis initiation, according to data presented at ASN Kidney Week.

News
October 24, 2023
3 min read
Save

Catheter-directed thrombolysis for PE confers less bleeding vs. mechanical thrombectomy

Catheter-directed thrombolysis for PE confers less bleeding vs. mechanical thrombectomy

SAN FRANCISCO — In the REAL-PE study of a real-world population of patients with pulmonary embolism, catheter-directed thrombolysis was associated with reduced risk for major bleeding compared with mechanical thrombectomy.

News
July 25, 2023
1 min read
Save

Catheter for mapping of complex cardiac arrhythmias launched

Catheter for mapping of complex cardiac arrhythmias launched

Biosense Webster announced the U.S. launch of a catheter to help electrophysiologists with mapping complex cardiac arrhythmias.

News
May 24, 2023
3 min read
Save

Transfusion policies may negatively affect outcomes after central catheter placement

Transfusion policies may negatively affect outcomes after central catheter placement

Withholding prophylactic platelet transfusion before placement of a central venous catheter in patients with severe thrombocytopenia resulted in more catheter-related bleeding events, results of a randomized noninferiority trial showed.

News
February 13, 2023
5 min read
Save

In nephrology, the conundrum regarding vascular access choice continues

In nephrology, the conundrum regarding vascular access choice continues

“Vascular access is the Achilles’ heel of dialysis therapy.”

News
January 12, 2023
2 min read
Save

Higher plasma omeintin-1 level correlates with reduced subsequent hospital admission, stay

Higher plasma omeintin-1 level correlates with reduced subsequent hospital admission, stay

Among patients on incident peritoneal dialysis, higher plasma omeintin-1 level quartile correlates with reduced subsequent hospital admissions and shorter hospital stays, according to data published in Kidney Medicine.

News
December 16, 2022
1 min read
Save

FDA designates recall of central venous access, catheter kits as class I

FDA designates recall of central venous access, catheter kits as class I

The FDA announced that Teleflex and Arrow International LLC are recalling both the Arrow MAC Two-Lumen Central Venous Access Kit and the Arrow Pressure Injectable Arrowg+ard Blue Plus Three-Lumen Central Venous Catheter Kit.

News
August 08, 2022
2 min read
Save

Meta-analysis: Rhythm control with catheter ablation ‘preferred treatment’ in AF, HFrEF

Meta-analysis: Rhythm control with catheter ablation ‘preferred treatment’ in AF, HFrEF

In patients with atrial fibrillation and concurrent HF with reduced ejection fraction, catheter ablation significantly reduced all-cause mortality compared with medical therapy, according to a new meta-analysis.

News
April 15, 2022
4 min watch
Save

VIDEO: Transition costs are high when patients switch from PD to HHD

VIDEO: Transition costs are high when patients switch from PD to HHD

BOSTON — In this video from the National Kidney Foundation Spring Clinical Meetings, Eric D. Weinhandl, PhD, MS, talks about the hidden costs in helping patients transition from peritoneal dialysis to home hemodialysis.

View more